Decongestants for dilating the nasal cavity, a randomised, blinded, prospective study to prevent iatrogenic epistaxis during nasotracheal intubatio

Completed

• Conditions: epistaxis; nasal trauma; 10069888

• Registration Number: NL-OMON41173
• Lead Sponsor: Catharina-ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 180

Inclusion Criteria

o Age older than 18 years
o Nasal intubation indicated and required for the planned surgery
o Informed consent

Exclusion Criteria

o Age less than 18 years old
o COPD Gold 3 or 4
o Severe dyspnoe
o (History of) nasal trauma or anatomical deformities
o Known allergy to any of the medications used

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>• Severity of the epistaxis<br /><br>• Requiring suction<br /><br>• Navigability of the tube during nasal passage</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>• Number of attempts<br /><br>• Resistance during intubation<br /><br>• Difficulty of intubation (grade of intubation)<br /><br>• Evaluation of nasal complications<br /><br>• Persistent nasal bleeding<br /><br>• Nasal pain (NRS-score)<br /><br>• Nasal trauma<br /><br>• Difficulty of nasal breathing</p><br>